Last 47 quarters of trend data · Healthcare · Medical - Diagnostics & Research
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -258.84 | — | — | 163.64 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 24.43 | 12.92 | 10.16 | 11.77 | 9.32 | 10.54 | 9.49 | 10.37 | 8.93 | 8.05 | 7.51 | 6.01 | 4.75 | 5.29 | 6.42 | 4.55 | 5.05 | 4.32 | 5.01 | 12.49 | 16.31 |
| — | +22.6% | +7.0% | +13.5% | +4.4% | +31.0% | +26.4% | +72.6% | +88.1% | +52.1% | +17.1% | +32.0% | -5.9% | +22.5% | +28.2% | -63.6% | -69.0% | -75.5% | -65.3% | -30.3% | +9.5% | |
| P/B Ratio | 31.41 | 21.35 | 15.95 | 18.29 | 17.64 | 18.49 | 15.37 | 16.52 | 17.89 | 15.90 | 13.91 | 9.76 | 6.49 | 9.28 | 9.54 | 5.60 | 11.76 | 7.70 | 7.17 | 13.23 | 13.59 |
| — | +15.5% | +3.8% | +10.7% | -1.4% | +16.3% | +10.5% | +69.1% | +175.4% | +71.4% | +45.9% | +74.3% | -44.8% | +20.5% | +33.0% | -57.7% | -13.5% | -77.0% | -69.7% | -20.1% | +24.6% | |
| P/FCF | 516.41 | — | 392.30 | 207.06 | 225.50 | 493.31 | 210.44 | 141.96 | 110.74 | — | 413.16 | — | — | — | — | — | — | — | — | — | — |
| — | — | +86.4% | +45.9% | +103.6% | — | -49.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.8% | 64.5% | 64.8% | 67.1% | 64.9% | 63.5% | 63.2% | 62.9% | 61.8% | 58.8% | 56.7% | 51.4% | 45.1% | 45.2% | 38.7% | 41.4% | 44.7% | 44.9% | 46.8% | 45.6% | 48.5% |
| — | +1.5% | +2.5% | +6.7% | +5.0% | +7.9% | +11.4% | +22.5% | +37.0% | +30.0% | +46.5% | +24.1% | +0.9% | +0.8% | -17.3% | -9.2% | -7.9% | -3.3% | -16.6% | -2.4% | +2.8% | |
| Operating Margin | -13.4% | -10.1% | -13.4% | -3.4% | -16.5% | -20.2% | -15.8% | -13.6% | -8.9% | -10.6% | -20.2% | -27.2% | -41.4% | -43.0% | -57.2% | -65.3% | -56.5% | -72.2% | -70.6% | -80.7% | -95.0% |
| — | +50.1% | +14.9% | +74.8% | -84.2% | -90.1% | +21.9% | +50.0% | +78.4% | +75.3% | +64.7% | +58.4% | +26.8% | +40.4% | +19.0% | +19.2% | +40.5% | +11.1% | -70.7% | -22.6% | -67.1% | |
| Net Margin | -9.0% | -8.9% | -12.2% | 7.1% | -14.8% | -18.5% | -13.3% | -11.3% | -7.2% | -9.1% | -18.4% | -25.1% | -40.6% | -42.4% | -56.6% | -65.6% | -57.7% | -73.2% | -71.4% | -81.2% | -95.7% |
| — | +51.8% | +8.4% | +162.9% | -105.8% | -103.7% | +27.4% | +55.0% | +82.3% | +78.6% | +67.5% | +61.8% | +29.5% | +42.1% | +20.7% | +19.2% | +39.7% | +10.4% | -70.3% | -19.5% | -61.0% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -14.3% | -3.7% | -4.9% | 3.2% | -7.0% | -8.1% | -5.5% | -5.2% | -3.7% | -4.6% | -8.7% | -10.1% | -15.8% | -17.8% | -20.2% | -26.7% | -30.1% | -29.4% | -23.2% | -19.9% | -28.6% |
| — | +54.1% | +11.2% | +161.5% | -90.2% | -76.7% | +36.6% | +48.5% | +76.7% | +74.1% | +57.1% | +62.3% | +47.6% | +39.6% | +12.9% | -34.2% | -5.4% | +14.9% | -55.9% | -33.1% | -106.0% | |
| ROA | -10.0% | -2.5% | -3.3% | 2.2% | -4.9% | -5.8% | -3.9% | -3.3% | -2.0% | -2.5% | -4.6% | -5.4% | -8.1% | -8.6% | -10.1% | -11.9% | -11.7% | -13.1% | -11.6% | -11.0% | -14.0% |
| — | +56.1% | +15.8% | +166.0% | -140.7% | -130.5% | +15.1% | +38.8% | +74.9% | +70.9% | +54.0% | +54.5% | +30.8% | +34.2% | +13.3% | -7.5% | +16.4% | +1.4% | -66.4% | -37.8% | -104.0% | |
| ROIC | -36.1% | -6.0% | -7.9% | -2.7% | -17.2% | -18.3% | -13.2% | -10.8% | -6.3% | -7.3% | -11.3% | -11.3% | -13.7% | -12.5% | -15.0% | -15.1% | -12.1% | -13.9% | -11.7% | -10.4% | -13.5% |
| — | +67.2% | +40.3% | +74.9% | -173.4% | -149.6% | -16.8% | +4.2% | +54.0% | +41.2% | +24.8% | +25.4% | -13.0% | +10.3% | -28.3% | -45.5% | +10.3% | -5.8% | -75.3% | -24.0% | -78.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.13 | 0.13 | 0.14 | 0.13 | 0.16 | 0.16 | 0.16 | 0.16 | 0.54 | 0.52 | 0.55 | 0.58 | 0.56 | 0.75 | 0.68 | 0.63 | 1.15 | 0.90 | 0.74 | 0.61 | 0.51 |
| — | -16.8% | -14.2% | -20.0% | -70.7% | -69.9% | -71.5% | -72.9% | -4.0% | -29.8% | -19.1% | -8.7% | -51.0% | -17.6% | -7.9% | +4.0% | +126.6% | -29.8% | -28.3% | +5.2% | -2.0% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 3.39 | 3.00 | 2.96 | 3.39 | 3.27 | 3.72 | 3.87 | 4.00 | 4.39 | 4.14 | 4.12 | 4.10 | 4.37 | 3.85 | 3.88 | 3.90 | 3.10 | 3.58 | 4.24 | 4.99 | 5.96 |
| — | -19.4% | -23.6% | -15.2% | -25.4% | -10.1% | -6.1% | -2.4% | +0.4% | +7.5% | +6.2% | +4.9% | +40.8% | +7.4% | -8.5% | -21.8% | -48.0% | -4.1% | -10.5% | +15.2% | +27.5% | |
| Quick Ratio | 3.24 | 2.85 | 2.83 | 3.24 | 3.13 | 3.58 | 3.74 | 3.87 | 4.23 | 4.01 | 3.98 | 3.96 | 4.23 | 3.69 | 3.74 | 3.79 | 2.95 | 3.46 | 4.13 | 4.87 | 5.82 |
| — | -20.3% | -24.2% | -16.3% | -26.0% | -10.7% | -6.2% | -2.4% | +0.0% | +8.5% | +6.4% | +4.6% | +43.1% | +6.7% | -9.5% | -22.2% | -49.3% | -3.7% | -10.1% | +15.0% | +27.4% | |
| Interest Coverage | -64.89 | -74.54 | -96.08 | -0.86 | -82.58 | -96.83 | -65.43 | -41.67 | -8.82 | -10.70 | -20.50 | -23.73 | -32.46 | -33.97 | -43.68 | -50.65 | -51.06 | -66.42 | -65.32 | -66.63 | -71.67 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NTRA stock.
Natera, Inc.'s current P/E is -258.8x. The average P/E over the last 1 quarters is 163.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Natera, Inc.'s current operating margin is -13.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Natera, Inc.'s business trajectory between earnings reports.